by jlohrconsulting | Oct 24, 2025 | Uncategorized
Eur Child Adolesc Psychiatry. 2025 Oct 24. doi: 10.1007/s00787-025-02897-1. Online ahead of print. ABSTRACT Ketamine and esketamine have been approved as an adjunctive therapy for treatment-resistant major depressive disorder with acute suicidal ideation and behavior...
by jlohrconsulting | Oct 24, 2025 | Uncategorized
Metab Brain Dis. 2025 Oct 24;40(8):297. doi: 10.1007/s11011-025-01725-4. ABSTRACT Ketamine (KET) is a drug that has been used as an anesthetic for many years. However, in the last two decades, new properties have been discovered that make it useful in treating various...
by jlohrconsulting | Oct 24, 2025 | Uncategorized
Psychiatr Q. 2025 Oct 24. doi: 10.1007/s11126-025-10223-w. Online ahead of print. ABSTRACT Despite extensive research, identifying reliable diagnostic biomarkers for MDD remains an open question. This systematic review quantifies the most promising diagnostic...
by jlohrconsulting | Oct 24, 2025 | Uncategorized
Discov Ment Health. 2025 Oct 24;5(1):159. doi: 10.1007/s44192-025-00224-3. ABSTRACT BACKGROUND: Mental health challenges, including anxiety, stress, depression, sleep disturbance and cognitive deficits, are prevalent among athletes due to continuous overtraining or...
by jlohrconsulting | Oct 24, 2025 | Uncategorized
Aging Clin Exp Res. 2025 Oct 24;37(1):299. doi: 10.1007/s40520-025-03209-y. ABSTRACT OBJECTIVE: Identifying cost-effective biomarkers for chronic disease screening remains a global challenge. This study examined sex- and age-specific associations between relative...
Recent Comments